Skip to search formSkip to main contentSkip to account menu

Refludan

Known as: Aventis Brand Lepirudin, Refludin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Abstract  Refludan (lepirudin‐rDNA for injection) is the first direct thrombin inhibitor approved by the United States FDA for… 
2005
2005
Le traitement par lepirudine (Refludan ®), hirudine recombinante, est utilise pour les patients atteints de thrombopenie a l… 
2001
2001
Treatment of critically ill patients who have heparin-induced thrombocytopenia and throm bosis (HITT) and also renal failure is a… 
2000
2000
Purpose: To report the case of a patient with HIT that received a prolonged infusion of r-hirudin (lepirudin; Refludan®; Hoechst… 
1998
1998
  • A. Camez
  • 1998
  • Corpus ID: 36614716
OBJECTIVES To assess morbidity and mortality in patients treated with Refludan for heparin-induced thrombocytopenia type II in… 
1997
1997
In a recent issue of Nephron Berlot and Lucchese [1] reported their management of heparin-associated thrombocytopenia (HAT…